These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16363425)

  • 1. [Cardiovascular risk factors: an update].
    Amouyel P
    Rev Prat; 2005 Oct; 55(16):1755-63. PubMed ID: 16363425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Global cardiovascular risk: definition, evaluation and management strategies. Round table no. 1. XV].
    Amouyel P; Deverly A
    Therapie; 2000; 55(4):533-9. PubMed ID: 11098732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor management: antiatherogenic therapies.
    Gielen S; Sandri M; Schuler G; Teupser D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S29-36. PubMed ID: 19675434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease on a global scale: defining the path forward for research and practice.
    Mark DB; Van de Werf FJ; Simes RJ; White HD; Wallentin LC; Califf RM; Armstrong PW;
    Eur Heart J; 2007 Nov; 28(21):2678-84. PubMed ID: 17940081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future directions of cardiovascular risk prediction.
    Smith SC
    Am J Cardiol; 2006 Jan; 97(2A):28A-32A. PubMed ID: 16442934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New strategies in cardiovascular prevention].
    Moreno J; Alegría-Barrero E; Cordero A; Fernández-Jarne E; Sáenz de Buruaga JD
    Rev Med Univ Navarra; 2005; 49(3):9-15. PubMed ID: 16400972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
    Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
    Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender disparities in cardiovascular disease care among commercial and medicare managed care plans.
    Chou AF; Wong L; Weisman CS; Chan S; Bierman AS; Correa-de-Araujo R; Scholle SH
    Womens Health Issues; 2007; 17(3):139-49. PubMed ID: 17481918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
    Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
    Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular prevention and large clinical trials].
    Gueyffier F
    Rev Prat; 2005 Oct; 55(16):1774-82. PubMed ID: 16363427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An appeal for reimbursement for innovative prevention measures in patient cardiovascular education.
    Frohlich ED
    Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):175. PubMed ID: 18368009
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice.
    van der Weijden T; Bos LB; Koelewijn-van Loon MS
    Curr Opin Cardiol; 2008 Sep; 23(5):471-6. PubMed ID: 18670259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease.
    Bush RL; Kallen MA; Liles DR; Bates JT; Petersen LA
    J Surg Res; 2008 Apr; 145(2):313-9. PubMed ID: 18222479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing cardiovascular disease in Kentucky: epidemiology, trends, and strategies for the future.
    Rugg SS; Bailey AL; Browning SR
    J Ky Med Assoc; 2008 Apr; 106(4):149-61; quiz 149, 162-3. PubMed ID: 18478845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.